UK court: Pfizer issued ‘groundless threats’ over Lyrica patent

11-09-2015

UK court: Pfizer issued ‘groundless threats’ over Lyrica patent

360b / Shutterstock.com

The English High Court has ruled that Pfizer’s second medical use patent covering its drug Lyrica (pregabalin) is invalid and that the pharmaceutical company is liable for making “groundless threats” of infringement.


Pfizer; Lyrica; Allergan; patent infringement; English High Court; Mylan

LSIPR